Website
N/ATelephone
61.3.9824.5254
Address
Level 3 62 Lygon Street Carlton, Victoria (VIC) 3053
Description
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.13
Trade Value (12mth)
AU$17,995.00
1 week
3.7%
1 month
-6.67%
YTD
-61.64%
1 year
-77.19%
All time high
0.45
EPS 3 yr Growth
6794.40%
EBITDA Margin
%
Operating Cashflow
-$23m
Free Cash Flow Return
-63.40%
ROIC
-132.30%
Interest Coverage
-55.00
Quick Ratio
1.30
Shares on Issue (Fully Dilluted)
446m
HALO Sector
Healthcare
Next Company Report Date
25-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
03 October 24 |
Significant progress with B7-H3 targeting radio-antibody
×
Significant progress with B7-H3 targeting radio-antibody |
03 October 24 |
Initial Director's Interest Notice - ND
×
Initial Director's Interest Notice - ND |
02 October 24 |
Appointment of Noel Donnelly as Non-Executive Director
×
Appointment of Noel Donnelly as Non-Executive Director |
02 October 24 |
RAD to present at JonesResearch Radiopharma Day
×
RAD to present at JonesResearch Radiopharma Day |
30 September 24 |
Annual Report
×
Annual Report |
30 September 24 |
Corporate Governance Statement and Appendix 4G
×
Corporate Governance Statement and Appendix 4G |
30 September 24 |
ESG Report
×
ESG Report |
19 September 24 |
RAD Launching American Depositary Receipt (ADR) Program
×
RAD Launching American Depositary Receipt (ADR) Program |
18 September 24 |
Becoming a substantial holder (PH)
×
Becoming a substantial holder (PH) |
18 September 24 |
Change of Director's Interest Notice (x6)
×
Change of Director's Interest Notice (x6) |
13 September 24 |
Application for quotation of securities - RAD
×
Application for quotation of securities - RAD |
13 September 24 |
Notice Under Section 708A
×
Notice Under Section 708A |
13 September 24 |
Notification regarding unquoted securities - RAD
×
Notification regarding unquoted securities - RAD |
30 August 24 |
Appendix 4E and Preliminary Final Report
×
Appendix 4E and Preliminary Final Report |
29 August 24 |
RAD
×
RAD |
29 August 24 |
Change in substantial holding
×
Change in substantial holding |
28 August 24 |
Application for quotation of securities - RAD
×
Application for quotation of securities - RAD |
28 August 24 |
Placement Options Range of Units and Top 20 Holders
×
Placement Options Range of Units and Top 20 Holders |
27 August 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
27 August 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
26 August 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
26 August 24 |
RAD increases ownership in Radiopharm Ventures to 75%
×
RAD increases ownership in Radiopharm Ventures to 75% |
23 August 24 |
Application for quotation of securities - RAD
×
Application for quotation of securities - RAD |
23 August 24 |
Notification regarding unquoted securities - RAD
×
Notification regarding unquoted securities - RAD |
23 August 24 |
Notice Under Section 708A
×
Notice Under Section 708A |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.